Indraprastha Medical (NSE:INDRAMEDCO) EBIT : ₹1,513 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Indraprastha Medical EBIT?

Indraprastha Medical's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was ₹415 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,513 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Indraprastha Medical's annualized ROC % for the quarter that ended in Dec. 2023 was 25.10%. Indraprastha Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 53.37%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Indraprastha Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.45%.

Indraprastha Medical EBIT Historical Data

The historical data trend for Indraprastha Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indraprastha Medical EBIT Chart

Indraprastha Medical Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

476.22

493.23

42.90

796.80

1,176.40

Indraprastha Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															302.80	242.50	410.10	445.00	415.40

Competitive Comparison of Indraprastha Medical's EBIT

For the Medical Care Facilities subindustry, Indraprastha Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indraprastha Medical's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indraprastha Medical's EV-to-EBIT falls into.

Indraprastha Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,513 Mil.

Indraprastha Medical (NSE:INDRAMEDCO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Indraprastha Medical's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	1490.8 * ( 1 - 27.61% )	/	( (4299.9	+	0)	/ 1 )
=	1079.19012	/	4299.9
=	25.10 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6675.6	-	1421.1	-	( 2136.8	-	max(0, 2070.1	-	3024.7	+	2136.8	))
=	4299.9

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Indraprastha Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1661.6	/	( ( (3113.5 + max(-1166.4, 0))	+	(0 + max(0, 0)) )	/	1 )
=	1661.6	/	( ( 3113.5	+	0 )	/	1 )
=	1661.6	/	3113.5
=	53.37 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(683.8	+	79.6	+	124.5)	-	(1421.1	+	0	+	633.2)
=	-1166.4

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Indraprastha Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	1513	/	20319.465
	=	7.45 %

Indraprastha Medical EBIT Related Terms

Thank you for viewing the detailed overview of Indraprastha Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Indraprastha Medical (NSE:INDRAMEDCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indraprastha Medical Corp Ltd (NSE:INDRAMEDCO) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

532150:India

Address

Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076

Website

https://delhi.apollohospitals.com

Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.

Indraprastha Medical (NSE:INDRAMEDCO) Headlines

No Headlines